Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ThisCART19A in Auto-CAR T Relapsed B-cell NHL
NCT05691153Phase 1Unknown
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Dec 2022
- Primary completion
- Nov 2025
- Modality
- Gene Editing, Gene Silencing, CAR-T Cells
- Countries
- 1
01
Overview
Phase 1, open-label trial of thiscart19a in B-cell non-Hodgkin lymphoma (B-NHL), sponsored by First Affiliated Hospital of Soochow University. Status: unknown.
02
Drugs
thiscart19a
03
Conditions
B-cell non-Hodgkin lymphoma (B-NHL)
Beyond the preview
Go deeper on NCT05691153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05691153.